LGSCX
Price
$16.20
Change
-$0.11 (-0.67%)
Updated
Jul 31 closing price
Net Assets
148.56M
NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

LGSCX vs NAESX

LGSCX vs NAESX Comparison Chart in %
View a ticker or compare two or three
VS
LGSCX vs. NAESX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGSCX is a Hold and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. LGSCX (149M). NAESX pays higher dividends than LGSCX: NAESX (1.10) vs LGSCX (0.01). LGSCX was incepted earlier than NAESX: LGSCX (24 years) vs NAESX (66 years). LGSCX (1.95) is less costly to investors than NAESX (0.17). LGSCX is a more actively managed with annual turnover of: 48.00 vs. NAESX (17.00). LGSCX (0) and NAESX (0) have matching initial minimum investment requirements. LGSCX annual gain was more profitable for investors over the last year : 25.89 vs. NAESX (22.56). NAESX return over 5 years is better than : 34.95 vs. LGSCX (8.50).
LGSCXNAESXLGSCX / NAESX
Total Expense Ratio1.300.17765%
Annual Report Gross Expense Ratio1.950.171,147%
Fund Existence24 years66 years-
Gain YTD16.63114.563114%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets149M189B0%
Annual Yield % from dividends0.011.101%
Returns for 1 year25.8922.56115%
Returns for 3 years44.3143.30102%
Returns for 5 years8.5034.9524%
Returns for 10 years37.52155.2824%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv